Back to Article List

Health claim evaluation on fructan mixture and normal defecation published by EFSA

European Union

Aug 17, 2021

On August 12, EFSA published  an evaluation of a health claim pursuant to Article 13(5) of Regulation (EC) No 1924/2006: Frutalose®, a mixture of fructans obtained from enzymatic hydrolysis of chicory inulin, and normal defecation.

One human intervention study showed an effect of Frutalose® on the maintenance of normal defecation by increasing stool frequency and improving stool consistency (softer stools) when consumed daily at a dose of 15 g for 8 weeks. The results have not been replicated in other studies. There is a plausible mechanism by which Frutalose® could exert the claimed effect. The Panel concludes that the evidence provided is insufficient to establish a cause and effect relationship between the consumption of Frutalose® and maintenance of normal defecation under the proposed conditions of use.

For further information (in English), click on the Link

Subscribe to our newsletter

The best industry insight in your mailbox